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T
he issue of medication errors (ME) is not a new 
concern. More than 50 years ago Barker et al’s (1962) 
study acknowledged that ME were a much bigger 
problem than anyone realised and that on a daily basis 
patients were harmed by providers of health care. As a 
potentially high-risk therapy, medication administration and the 
associated ME remain a significant contributor to patient harm 
(Leape et al, 2005; Kelly et al, 2006; Aspden et al, 2007; World 
Health Organization (WHO), 2017a; 2017b). The Institute of 
Medicine (IOM) report, ‘To Err Is Human: Building a Safer Health 
System’ (Kohn et al, 2000), stated that ME were a significant 
cause of morbidity and mortality, with nearly 100 000 deaths, 1 
million injuries, and 17 billion dollars annually attributable to 
ME. In addition, the IOM identified that hospitalised patients 
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ABSTRACT
This article employs a paediatric case study, involving a 3-year-old child who 
had an anaphylactic reaction that occurred as a result of the multidisciplinary 
team’s failure to identify and acknowledge the patient’s documented ‘known 
allergy’ status. It examines and reconsiders the ongoing healthcare dilemma 
of medication errors and recommends that known allergy status should be 
considered the second medication administration ‘right’ before the prescribing, 
transcribing, dispensing and administration of any drug. Identifying and 
documenting drug allergy status is particularly important when caring for 
paediatric patients, because they cannot speak for themselves and must rely 
on their parents, guardians or health professionals as patient advocates. The 
literature states that medication errors can be prevented by employing a ‘rights 
of medication administration’ format, whether that be the familiar ‘5 rights’ or a 
more detailed list. However, none of these formats specify known allergy status 
as a distinct ‘right’. The medication safety literature is also found wanting in 
respect of the known allergy status of the patient. When health professionals 
employ a medication administration rights format prior to prescribing, 
transcribing, dispensing or administering a medication, the ‘known allergy 
status’ of the patient should be a transparent inclusion.
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were potentially subjected to at least one ME a day, taking into 
account near misses, and that not all detected errors were reported 
(Aspden et al, 2007). Other studies have also indicated that up 
to 30% of patients will experience a harmful event such as ME 
or wrong procedures due to incorrect patient identification 
during their hospitalisation (Fowler et al, 2008; Griffin and 
Classen, 2008). A seminal study by Wilson et al (1999) observed 
that human error was a significant factor, with 81% of harmful 
events associated with human factors, such as non-caring attitudes 
and behaviour, and a lack of knowledge. Vincent et al (2001) 
categorised 48% of these harmful occurrences as preventable, 
which has been supported by other studies (Rex et al, 2000; 
Regenbogen et al, 2007). In the classic Harvard medical practice 
study, Leape and colleagues (1991) found that 1 in 4 of these 
harmful events was the result of negligence and 58% were 
deemed preventable. 
Some of the most common types of harmful events that 
resulted in patient mortality involved administration of a drug to 
patient with a known allergy to that drug or a similar medication. 
Supplementary reports stated that 1 in 10 patients experience 
medication-related harm, comparably involving a documented 
known allergy status (Barker et al, 1962; Bates et al, 1995; Bond 
et al, 2002; Rothschild et al, 2005). The Joint Commission 
International (JCI) publishes revised National Patient Safety 
Goals each year to assist healthcare organisations to improve 
patient safety; there are specific goals relating to improving 
medication administration and patient identification (JCI, 2019).
This article considers the ongoing issue of ME in general 
and in particular the prescribing and administration of drugs 
to a patient with a known allergy. It considers a case involving 
a young child who had an anaphylactic reaction that occurred 
as a result of the multidisciplinary team’s failure to identify and 
acknowledge the patient’s documented ‘known allergy’ status.
Background
Medication errors
The phenomenon of ME is among the most frequent and 
widespread of healthcare-related mistakes that cause iatrogenic 
patient harm (Rothschild, 2005; Aspden et al, 2007; Dhawan et al, 
2017). ME have also been clarified as any preventable event that 
may cause or lead to patient harm while the medication is in the 
control of the health professional, patient or consumer (Leape, 
2005; da Silva and Krishnamurthy, 2016). These potentially 
harmful events may be related to professional practice, healthcare 
products, procedures and systems (National Coordinating 
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